Table 7 Sensitivity analysis: use of inverse-probability weighting (IPW) to account for missing data.

From: Association of sleep duration in middle and old age with incidence of dementia

 

N cases/N total

Main analysis

Analysis using IPW to account for missing data

HRa (95% CI)

P valueb

HRa (95% CI)

P valueb

Sleep duration at age 50

 Short: ≤6 h

211/3149

1.22 (1.01–1.48)

0.04

1.21 (0.99–1.48)

0.06

 Normal: 7 h

219/3624

1 (ref.)

 

1 (ref.)

 

 Long: ≥8 h

91/1186

1.25 (0.98–1.60)

0.07

1.28 (0.99–1.66)

0.06

Sleep duration at age 60

 Short: ≤6 h

192/2759

1.37 (1.10–1.72)

0.005

1.31 (1.03–1.66)

0.03

 Normal: 7 h

142/2988

1 (ref.)

 

1 (ref.)

 

 Long: ≥8 h

75/1417

1.15 (0.87–1.52)

0.34

1.25 (0.93–1.66)

0.14

Sleep duration at age 70

 Short: ≤6 h

171/2429

1.24 (0.98–1.57)

0.10

1.14 (0.88–1.46)

0.32

 Normal: 7 h

131/2578

1 (ref.)

 

1 (ref.)

 

 Long: ≥8 h

90/1509

1.15 (0.88–1.51)

0.60

1.14 (0.85–1.52)

0.39

Trajectories of sleep duration between age 50 and 70

 Persistent short

103/1358

1.30 (1.00–1.69)

0.048

1.24 (0.94–1.64)

0.13

 Persistent normal

141/2520

1 (ref.)

 

1 (ref.)

 

 Persistent long

35/461

1.28 (0.88–1.85)

0.20

1.33 (0.90–1.96)

0.15

 Change from short to normal

61/1086

1.20 (0.89–1.63)

0.23

1.21 (0.88–1.69)

0.24

 Change from normal to long

47/946

1.02 (0.73–1.42)

0.90

1.02 (0.71–1.45)

0.93

 Change from normal to short

39/504

1.13 (0.79–1.62)

0.50

1.12 (0.75–1.68)

0.57

Accelerometer-assessed sleep duration

 Tertile 1: 1 h 16 min–6 h 13 min

53/1296

1.63 (1.04–2.57)

0.03

1.63 (1.03–2.59)

0.04

 Tertile 2: 6 h 14 min–7 h 0 min

31/1296

1 (ref.)

 

1 (ref.)

 

 Tertile 3: 7 h 1 min–10 h 6 min

27/1296

0.78 (0.46–1.32)

0.36

0.82 (0.47–1.41)

0.82

  1. CI confidence intervals, HR hazard ratio, IPW inverse-probability weighting, h hour, min minute.
  2. aHR estimated from a Cox regression adjusted for age (timescale), sex, ethnicity, education, and marital status, alcohol consumption, physical activity, smoking status, and fruit and vegetable consumption, BMI, hypertension, diabetes, cardiovascular disease, GHQ depression, and CNS medications.
  3. bTwo-sided for HR in comparison with the reference (ref.) category, without adjustment for multiple comparisons.